VeriMomБезопасен ли acetyl farnesylcysteine при беременности?
No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
Related ingredients
Frequently asked questions
- Безопасен ли acetyl farnesylcysteine при беременности?
- No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
- Безопасен ли acetyl farnesylcysteine при грудном вскармливании?
- No evidence of reproductive or lactation‑related toxicity in the scientific literature or regulatory assessments. Dermal application to the breast could lead to low but measurable maternal systemic exposure (as for pregnancy), so exposure given as 1; no data show transfer into breastmilk or effects on nursing infants.
- Безопасен ли acetyl farnesylcysteine для кожи малыша?
- No infant‑specific toxicology found. Because topical AFC shows measurable activity/absorption in skin studies, baby exposure is increased by +1 to account for immature barrier and higher surface‑area‑to‑weight (adult e=1 → infant e=2). No data indicate infant‑specific hazard or mechanisms, so h and m remain 0.
- Как VeriMom оценивает acetyl farnesylcysteine?
- VeriMom оценивает acetyl farnesylcysteine в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы acetyl farnesylcysteine при беременности?
- См. наш список безопасных альтернатив acetyl farnesylcysteine с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.